Unlock stock picks and a broker-level newsfeed that powers Wall Street.

NasdaqGM - Nasdaq Real Time Price USD

Cronos Group Inc. (CRON)

Compare
1.7200
+0.1000
+(6.17%)
At close: April 9 at 4:00:02 PM EDT
Loading Chart for CRON
  • Previous Close 1.6200
  • Open 1.6200
  • Bid 1.7100 x 100
  • Ask 1.7200 x 300
  • Day's Range 1.6004 - 1.7350
  • 52 Week Range 1.6000 - 3.1400
  • Volume 1,509,520
  • Avg. Volume 1,557,288
  • Market Cap (intraday) 657.953M
  • Beta (5Y Monthly) 1.42
  • PE Ratio (TTM) 15.64
  • EPS (TTM) 0.1100
  • Earnings Date May 7, 2025 - May 12, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 1.91

Cronos Group Inc. operates as a cannabinoid company that engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally. The company offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brand names. Cronos Group Inc. was founded in 2012 and is based in Stayner, Canada.

www.thecronosgroup.com

459

Full Time Employees

December 31

Fiscal Year Ends

Recent News: CRON

View More

Performance Overview: CRON

Trailing total returns as of 4/9/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .

YTD Return

CRON
11.79%
S&P/TSX Composite index (^GSPTSE)
3.63%

1-Year Return

CRON
35.58%
S&P/TSX Composite index (^GSPTSE)
6.11%

3-Year Return

CRON
50.57%
S&P/TSX Composite index (^GSPTSE)
8.47%

5-Year Return

CRON
70.29%
S&P/TSX Composite index (^GSPTSE)
67.49%

Compare To: CRON

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: CRON

View More

Valuation Measures

Annual
As of 4/9/2025
  • Market Cap

    646.72M

  • Enterprise Value

    -210.07M

  • Trailing P/E

    15.58

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    5.57

  • Price/Book (mrq)

    0.62

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    34.93%

  • Return on Assets (ttm)

    -2.94%

  • Return on Equity (ttm)

    3.63%

  • Revenue (ttm)

    117.61M

  • Net Income Avi to Common (ttm)

    41.08M

  • Diluted EPS (ttm)

    0.1100

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    858.8M

  • Total Debt/Equity (mrq)

    0.18%

  • Levered Free Cash Flow (ttm)

    -26.29M

Research Analysis: CRON

View More

Company Insights: CRON

Research Reports: CRON

View More

People Also Watch